Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Simulations Plus (SLP) PT Raised to $55 at Craig-Hallum
January 7, 2022 9:21 AM ESTCraig-Hallum analyst Matthew Hewitt raised the price target on Simulations Plus (NASDAQ: SLP) to $55.00 (from $53.00) while maintaining a Buy rating following strong Q1.
... More